Woodline Partners LP Regulus Therapeutics Inc. Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Woodline Partners LP holds 948,702 shares of RGLS stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
948,702
Previous 947,685
0.11%
Holding current value
$1.45 Million
Previous $1.7 Million
12.21%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RGLS
# of Institutions
74Shares Held
56.5MCall Options Held
79.3KPut Options Held
20.3K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$19.7 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$9.9 Million0.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.65 Million1.15% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.52 Million1.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$6.26 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $22.4M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...